February 23, 2018 / 12:19 PM / 6 months ago

BRIEF-EMA Recommends Against Approval Of Puma Biotechnology's Breast Cancer Drug Neratinib‍​

Feb 23 (Reuters) - EU Medicines Agency:

* EU MEDICINES AGENCY RECOMMENDATIONS FOR FEBRUARY 2018

* EU MEDICINES AGENCY RECOMMENDATIONS FOR FEBRUARY 2018 BREAST CANCER DRUG NERATINIB

* EU MEDICINES AGENCY RECOMMENDS APPROVAL OF PFIZER'S MYLOTARG FOR TREATMENT OF ACUTE MYELOID LEUKAEMIA‍​‍​‍​ Source (bit.ly/2FtAttD) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below